Peritonitis
- Experimental TherapeuticsAnalysis of Paradoxical Efficacy of Carbapenems against Carbapenemase-Producing Escherichia coli in a Murine Model of Lethal Peritonitis
The clinical benefit of carbapenems against carbapenemase-producing Enterobacteriaceae (CPE) remains in question. MICs of imipenem (IMP) and ertapenem (ERT) against isogenic derivatives of the wild-type strain Escherichia coli CFT073 producing KPC-3, OXA-48, or NDM-1 were 0.25, 2, 16, and 64 mg/liter for IMP and 0.008, 0.5, 8, and 64 mg/liter for ERT,...
- Experimental TherapeuticsIntracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model
- Experimental TherapeuticsSystemic Antibacterial Activity of Novel Synthetic Cyclic Peptides